Extraordinary response to omalizumab in a child with severe chronic urticaria

European Annals of Allergy and Clinical Immunology

Volumn 46, Issue 1, 2014, Pages 41-42

  Asero, R ^a   Casalone, R ^b   Iemoli, E ^c  

^a CLINICA SAN CARLO   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic urticaria; Ciclosporin; Omalizumab; Therapy

Indexed keywords

CYCLOSPORIN A; D DIMER; HYDROXYZINE; IMMUNOGLOBULIN E; LEVOCETIRIZINE; MONTELUKAST; OMALIZUMAB; PREDNISONE;

ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CHILD; CHRONIC URTICARIA; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GRASS POLLEN; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MALE; PERCEPTION DEAFNESS; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFECTION; RHINOCONJUNCTIVITIS; SINGLE DRUG DOSE; TREATMENT RESPONSE; WEIGHT GAIN;

CHRONIC URTICARIA; CICLOSPORIN; OMALIZUMAB; THERAPY;

ANTI-ALLERGIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD; CHRONIC DISEASE; HUMANS; MALE; URTICARIA;

EID: 84896953336     PISSN: 17641489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Gimenez-Arnau A, et al. EAACI/GA2LEN;EDF;WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64:1417-26.
2. Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415-8.
3. Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol. 2007;99:190-3.
4. Sands MF, Blume JW, Schwartz SA. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol. 2007;120979-81.
5. Kaplan AP, Joseph K, Maykut RJ, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008;122:569-73.
6. Dreyfus DH. Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema. Ann Allergy Asthma Immunol. 2008;100:624-5.
7. Godse KV. Omalizumab in severe chronic urticaria. Indian J Dermatol Venereol Leprol. 2008;74:157-8.
8. Waibel KH, Reese DA, Hamilton RG, Devillez RL. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol. 2009;125:490-1.
9. Vestergaard C, Deleuran M. Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab. Acta Derm Venereol. 2010;90:443-4.
10. Krause K, Ardelean E, Kessler B, et al. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy. 2010;65:1494-5.
11. Ferrer M, Gamboa P, Sanz ML, et al. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol. 2011;127:1300-2.
12. Maurer M, Altrichter S, Bieber T, Biedermann T, Braautigam M, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol. 2011;128:202-9.
13. Saini S, Rosen KE, Hsieh HJ, Wong DA, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractort chronic idiopathic urticaria. J Allergy Clin Immunol. 2011;128:567-73.
14. Maurer M, Rosen K, Hsieh HJ, Saini S, Grattan C, Gimenez-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale T. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013; 368:2340-1.
15. Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S. Omalizumab- induced reductions in mast cell Fc epsilon RI expression and function. J Allergy Clin Immunol. 2004;114:527-30.
16. Eckman JA, Sterna PM, Kelly D, et al. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol. 2010;125:889-95.
17. MacGlashan DW, Bochner BS, Ademan DC, et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with an anti-IgE antibody. J Immunol. 1997;158:1438-45.
18. Noga O, Hanf G, Brachmann I, et al. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. J Allergy Clin Immunol. 2006;117(6):1493-1499.
19. Iemoli E, Piconi S, Fusi A, Borgonovo L, Borelli M, Trabattoni D: Immunological effects of omalizumab in chronic urticaria: a case report. J Investig Allergol Clin Immunol. 2010;20(3):252-254.